In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The infection with cytomegalovirus (CMV) is the first cause of congenital neurological
handicap of infectious origin. It is probable that the néonatale viral load is correlated
with becoming of infected new-born babies. Among the active antiviral treatments against CMV,
valacyclovir is the only whose fœtal and maternal tolerance was evaluated during the
pregnancy. Its harmlessness and its aptitude to decrease the CMV viral load justify to
evaluate it in a study. Decrease the fœtal viral load could make possible to decrease
symptomatology néonatale in a group of infected fœtuses.